An MRI Ancillary Study of a Malaria Fever Investigation
NCT05746819 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 181
Last updated 2024-04-15
Summary
This study will seek consent from parents of children enrolled in the Malaria FEVER study to obtain neuroimaging and 12-month neuropsychiatric outcomes data and kidney function on their child. The imaging and evaluations for this observational study will occur after the child has recovered from the acute malaria infection and has otherwise completed the RCT intervention and safety evaluations.
Conditions
- Brain Injuries
- Malaria
- MRI Imaging
- Neurocognitive Deficits
- Chronic Kidney Diseases
- Behavior Problem
Interventions
- OTHER
-
Aggressive antipyretics therapy of fever vs usual care in the Malaria RCT study
After clinical trial of the Malaria RCT study, this study will compare children allocated to aggressive antipyretic therapy vs. usual care on the prevalence of structural brain abnormalities after recovery from CNS malaria.
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH -
University of Rochester
lead OTHER
Principal Investigators
-
Karl B Seydel, PhD · Michigan State University, USA
Eligibility
- Min Age
- 2 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-02
- Primary Completion
- 2023-08-31
- Completion
- 2024-03-31
Countries
- Malawi
- Zambia
Study Locations
More Related Trials
-
DON in Pediatric Cerebral Malaria
NCT05478720 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Fetal Immunity to Falciparum Malaria
NCT00314899 ·Status: COMPLETED
-
MiMBa Pregnancy Registry
NCT04825782 ·Status: UNKNOWN
-
CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi
NCT00125489 ·Status: COMPLETED ·Phase: PHASE4
-
A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
NCT02374450 ·Status: COMPLETED
-
Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
NCT00619203 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Malawi
NCT01120145 ·Status: COMPLETED
-
Improved Management and in-Hospital Mortality
NCT00465777 ·Status: COMPLETED ·Phase: NA
-
Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian Children
NCT02504918 ·Status: COMPLETED
-
Prophylaxis Against Malaria to Enhance Child Development (PROTECT Study)
NCT02557425 ·Status: COMPLETED
-
Relationship Between HIV and Malaria in Ugandan Children
NCT00356824 ·Status: COMPLETED
-
Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria
NCT00124267 ·Status: UNKNOWN ·Phase: PHASE3
-
Child Follow-up Until 2 Years
NCT02800109 ·Status: COMPLETED
-
Clinical Evaluation of Long-term Sequelae in Patients With Severe Plasmodium Falciparum Malaria
NCT06992297 ·Status: COMPLETED ·Phase: NA
-
The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau
NCT00137566 ·Status: UNKNOWN ·Phase: PHASE4
-
Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector
NCT02199977 ·Status: COMPLETED ·Phase: NA
-
Nitrite Infusion in Children With Malaria
NCT04289558 ·Status: WITHDRAWN ·Phase: PHASE1
-
The Cytoadherence in Pediatric Malaria (CPM) Study
NCT00707200 ·Status: COMPLETED
-
Malaria Vaccine in Children in Mali
NCT00341250 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa
NCT00866619 ·Status: COMPLETED ·Phase: PHASE3
-
Malaria and the Safety of Iron Supplements and Iron Fortification
NCT01156896 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
NCT01388842 ·Status: COMPLETED ·Phase: PHASE2
-
Examination of Protective Factors Against Severe Malaria
NCT00342043 ·Status: COMPLETED
-
Community Dynamics of Malaria Transmission in Humans and Mosquitoes at Maferinyah Sub-Prefecture, Guinea
NCT04969913 ·Status: COMPLETED
-
Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda
NCT02094508 ·Status: COMPLETED